Latest Breaking News On - Agenzia italiana del farmaco - Page 1 : comparemela.com

Form 10-K Jaguar Health, Inc For: Dec 31

Form 10-K Jaguar Health, Inc For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

State of delawareUnited statesSan franciscoNew zealandFor postOmskaya oblastUnited kingdomHong kongSaudi arabiaUnited arab emiratesState of californiaCredit onNew yorkSouth koreaSouth africaGulf states

BioCryst Launches ORLADEYO (berotralstat) in Italy

19.02.2024 - RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2024 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA), has finalized reimbursement and recommended .

Charlie gayerBiocryst pharmaceuticals incItalian medicines agencyCryst pharmaceuticalsAgenzia italiana del farmacoBiocryst pharmaceuticals chartIocryst pharmaceuticals kursIocryst pharmaceuticals aktie

Philogen S p A announces receipt of the Good Manufacturing

Philogen S p A announces receipt of the Good Manufacturing
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New zealandUnited statesDuccio neriDario neriRosia sienaEuropean parliamentEuropean unionEuropean commissionAgenzia italiana del farmacoGood manufacturing practiceEuropean member stateRules governing medicinal productsMedicinal productsExecutive chairman

Philogen S p A announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

SIENA, Italy, Dec. 05, 2023 Philogen S.p.A. is pleased to announce that its new GMP facility located in Rosia Siena, is now GMP certified. The certification was granted by the GMP MED office of.

New zealandUnited statesDuccio neriDario neriRosia sienaEuropean parliamentEuropean unionEuropean commissionAgenzia italiana del farmacoGood manufacturing practiceEuropean member stateRules governing medicinal productsMedicinal productsExecutive chairman

Partner Therapeutics Announces Publication of 30-month Randomized Open Label Study of LEUKINE® in Combination with Whole Lung Lavage for Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

/PRNewswire/ Partner Therapeutics, Inc. (PTx) announced today that the European Respiratory Journal published the results of a prospective, randomized.

United statesMaurizio luisettiBruce trapnellFrancesca marianiIlaria campoPartner therapeutics incPartner therapeuticsEuropean respiratory journalPneumology unitSan matteoHospital medicalDoctor maurizio luisettiProfessor luisettiAgenzia italiana del farmacoHematopoietic syndromeAcute radiation syndrome